High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring

By Bernlochner Isabell   Mayer Katharina   Morath Tanja   Braun Siegmund   Schulz Stefanie   Schömig Albert   Koch Werner   Kastrati Adnan   Sibbing Dirk  

Platelets, Vol. 24, Iss. 6, 2013-09 ,pp. : 500-502

Informa Healthcare

Access to resources Recommend Favorite

Clopidogrel (Plavix®) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding

By Tanaka Kenichi A.   Szlam Fania   Kelly Andrew B.   Vega J. David   Levy Jerrold H.  

Platelets, Vol. 15, Iss. 5, 2004-08 ,pp. : 325-332

Informa Healthcare

Access to resources Recommend Favorite

What Can We Learn from Epidemiological Studies in Inflammatory Bowel Disease?

By  

Digestive Diseases, Vol. 35, Iss. 1-2, 2017-02 ,pp. : 69-73

Karger

Access to resources Recommend Favorite

Effect of 450-mg loading dose of clopidogrel on platelet function in Japanese patients undergoing coronary stent placement

By Fukushima Kenichi   Kobayashi Yoshio   Kitahara Hideki   Iwata Yo   Kuroda Nakabumi   Ooyama Masayuki   Nomura Fumio   Komuro Issei  

Heart and Vessels, Vol. 25, Iss. 3, 2010-05 ,pp. : 182-186

Springer Publishing Company

Access to resources Recommend Favorite

The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease

By Jagroop I. Anita   Matsagas Miltiadis I.   Geroulakos George   Mikhailidis Dimitri P.  

Platelets, Vol. 15, Iss. 2, 2004-03 ,pp. : 117-125

Informa Healthcare

Access to resources Recommend Favorite